Singer-songwriter and actress Mandy Moore talked about her real life Big Three, her children, and their experience with ...

New strategies may be needed to protect infants older than six months against the highly infectious Respiratory Syncytial Virus or RSV, new University of Queensland research has found. The study ...

Human challenge trials offer a complementary approach. By safely and deliberately exposing healthy adult volunteers to a well characterised virus under controlled conditions, researchers can generate ...

Market normalization reflects maturation, not decline - strategic transition creates opportunities in precision immunization, ...

Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory ...

What used to be a predictable “cold and flu season” has evolved into a formidable “triple threat” of the flu, RSV, and COVID-19—and now, the highly contagious norovirus is joining the headlines. For ...

Beyfortus is not a vaccine. It’s a monoclonal antibody designed to help protect babies from serious RSV lung infection during ...

GSK (NYSE:GSK) is one of the best value stocks to buy now. On February 17, GSK released new real-world evidence showing that ...

New FDA-approved immunizations are crucial for protecting infants from RSV, a leading cause of hospitalization for babies ...

The results indicate that safety in children under two years was consistent across both RSV seasons receiving Enflonsia.

I’ve spent a large part of my professional life working to improve the health of our Louisiana children. As the executive ...

In healthy, nonpregnant women, the multidose vial of RSVpreF vaccine produces immune responses and safety outcomes comparable ...